Related Experiment Video
Updated: Aug 18, 2026
Retroductal Submandibular Gland Instillation and Localized Fractionated Irradiation in a Rat Model of Salivary Hypofunction
Published on: April 24, 2016
Salivary gland tumors: pretherapy evaluation with PET
J W Keyes1, B A Harkness, K M Greven
1Department of Radiology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC 27157.
Purpose:
To determine whether positron emission tomography (PET) can help differentiate benign from malignant lesions of the salivary glands before surgery.
Materials And Methods:
Masses of the salivary glands were examined in 26 patients by means of computed tomography, magnetic resonance imaging, PET, biopsy (n = 18), and surgery. Contiguous PET scans were obtained from the midcranium to the lower chest 45 minutes after administration of 370 MBq (10 mCi) of fluorine-18 fluorodeoxyglucose (FDG). Standard uptake values (SUVs) were determined for all suspect lesions and for normal parotid glands and cerebellum.
Results:
All lesions were visualized, and all but two showed some increase in FDG uptake. PET findings helped correctly differentiate benign from malignant masses in 18 (69%) but were false-positive for malignancy in eight (31%). SUV analysis, lesion-to-normal SUV ratios, and lesion-to-cerebellar SUV ratios also failed to differentiate the lesions.
Conclusion:
FDG PET is not useful in classifying salivary gland tumors as benign or malignant.
